Can Radiomics Bridge the Gap Between Immunotherapy and Precision Medicine in Lung Cancer?

J Thorac Oncol. 2023 Jun;18(6):686-688. doi: 10.1016/j.jtho.2023.03.011.

Authors

Lukas Delasos¹, Anant Madabhushi², Pradnya D Patil³

Affiliations

¹ Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio.
² Department of Biomedical Engineering, Emory University, Atlanta, Georgia; Georgia Institute of Technology, Atlanta, Georgia; Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
³ Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio. Electronic address: patilp@ccf.org.

PMID: 37210178
DOI: 10.1016/j.jtho.2023.03.011

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Immunotherapy
Lung Neoplasms* / diagnostic imaging
Lung Neoplasms* / therapy
Precision Medicine